Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2012, Article ID 428075, 4 pages
Case Report

Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family

1Department of Molecular and Biochemical Genetics, Institute of Human Genetics, FRIGE House, Jodhpur Gam Road, Satellite, Ahmedabad, Gujarat 380 015, India
2Department of Obstetrics and Gynecology, Jehangir Hospital, Sassoon Road, Pune 411 001, India

Received 27 July 2012; Accepted 5 September 2012

Academic Editors: P. D. Cotter and B. Mittal

Copyright © 2012 Jayesh J. Sheth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Mitchell, M. Grompe, M. Lambert, and R. M. Tanguay, “Hypertyrosinemia,” in The Metabolic and Molecular Bases of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds., pp. 1777–1806, McGraw Hill, New York, NY, USA, 2001. View at Google Scholar
  2. M. De Braekeleer and J. Larochelle, “Genetic epidemiology of hereditary tyrosinemia in Quebec and Saguenay-Lac-St-Jean,” American Journal of Human Genetics, vol. 47, no. 2, pp. 302–307, 1990. View at Google Scholar · View at Scopus
  3. E. A. Kvittingen, “Hereditary tyrosinemia type I—An overview,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 46, no. 184, pp. 27–34, 1986. View at Google Scholar · View at Scopus
  4. L. S. King, C. Trahms, and C. R. Scott, Tyrosinemia Type 1 Gene Reviews, University of Washington, Seattle, Wash, USA, 2006.
  5. B. Lindblad, S. Lindstedt, and G. Steen, “On the enzymic defects in hereditary tyrosinemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 10, pp. 4641–4645, 1977. View at Google Scholar · View at Scopus
  6. S. B. Melancon, R. Gagne, A. Grenier, A. Lescault, L. Dallaire, C. Laberge et al., “Deficiency of fumarylacetoacetase in the acute form of hereditary tyrosinemia with reference to prenatal diagnosis,” in Pediatric Liver Disease, M. M. Fisher and C. C. Roy, Eds., pp. 223–235, Plenum, New York, NY, USA, 1983. View at Google Scholar
  7. E. Stoner, H. Starkman, and D. Wellner, “Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: Evidence of glutathione deficiency,” Pediatric Research, vol. 18, no. 12, pp. 1332–1336, 1984. View at Google Scholar · View at Scopus
  8. R. Gagne, A. Lescault, and A. Grenier, “Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid,” Prenatal Diagnosis, vol. 2, no. 3, pp. 185–188, 1982. View at Google Scholar · View at Scopus
  9. O. N. Elpeleg, A. Shaag, E. Holme et al., “Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I,” Human mutation, vol. 19, no. 1, pp. 80–81, 2002. View at Google Scholar · View at Scopus
  10. S. Bijarnia, R. D. Puri, J. Ruel, G. F. Gray, L. Jenkinson, and I. C. Verma, “Tyrosinemia type I—diagnostic issues and prenatal diagnosis,” Indian Journal of Pediatrics, vol. 73, no. 2, pp. 163–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Bergman, I. E. van den Berg, W. Brink, B. T. Poll-The, J. K. Ploos van Amstel, and R. Berger, “Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries,” Human Mutation, vol. 12, pp. 19–26, 1998. View at Google Scholar
  12. A. Bergeron, M. D'Astous, D. E. Timm, and R. M. Tanguay, “Structural and functional analysis of missense mutations in fumarylacetoacetate ydrolase, the gene deficient in hereditary tyrosinemia type 1,” Journal of Biological Chemistry, vol. 276, no. 18, pp. 15225–15231, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Arranz, F. Piñol, L. Kozak et al., “Splicing mutations, mainly IVS6.1 (G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients,” Human Mutation, vol. 20, no. 3, pp. 180–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Heath, R. G. F. Gray, P. McKierman, K. M. Au, E. Walker, and A. Green, “Mutation screening for tyrosinaemia type 1,” Journal of Inherited Metabolic Disease, vol. 25, no. 6, pp. 523–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Tchernitchko, M. Goossens, and H. Wajcman, “In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics,” Clinical Chemistry, vol. 50, no. 11, pp. 1974–1978, 2004. View at Publisher · View at Google Scholar · View at Scopus